Full Symposia Sessions

The Symposia will take place on Thursday, 30 October, Friday 31 October and Saturday, 1 November 2014.

Please click here to download all symposia as one PDF.

Title of symposium




Thursday, 30 October 2014 - 08:00 - 10:00

01. Progress in clinical trials for drug-sensitive TB: 2014 TB/Bacteriology and Immunology Andrew Vernon (USA),
Gavin Churchyard (South Africa)
02. Preparing frontline health workers for community-led change TB/ Nurses and Allied Professionals Netty Kamp (Netherlands) 117
03. How multi-sectoral approach and community engagement may strengthen programmatic management of TB in prisons Tuberculosis Fuad Mirzayev (Switzerland),
Rafael Mekhdiyev (Azerbaijan)
04. Tuberculosis and diabetes: from evidence to action Tuberculosis Kerri Viney (Australia),
Richard Brostrom (USA)
05. Next generation of eHealth for TB: systems that communicate Tuberculosis Job Van Rest (Netherlands),
Dennis Falzon (Switzerland)
06. Empirical treatment for TB among HIV-positive people: who, when, how? Update on trials in progress HIV Alison Grant (UK),
Salome Charalambous (South Africa)
07. Community engagement and relief of suffering in palliative care Civil Society Stephen Connor (USA) 116
08. Child pneumonia: innovative solutions for the next generation Adult and Child Lung Health Stephen M Graham (Australia),
Amy Ginsburg (USA)
09. Integrating community-based tobacco control activities in TB programmes: experience from multiple countries Tobacco Xiaolin Wei (Hong Kong)  120/121

Thursday, 30 October 2014 - 14:30 - 16:30

10. Shortened treatment regimens for MDR-TB: results from the field and future direction Tuberculosis I. D. Rusen (Canada),
Tara Ornstein (USA)
11. Can we reach the post-2015 WHO global TB targets? Tuberculosis Richard White (UK),
Anna Vassall (Netherlands)
12. Exploring the intersection between TB and maternal and neonatal health:  from research to implementation Tuberculosis Stacie C Stender (South Africa) 111
13. Innovations in airborne infection control Tuberculosis Amie Shao (USA),
Edward Nardell (USA)
14. Outstanding issues in HIV/AIDS HIV Anand Date (USA),
Marina Tadolini (Italy)
15. Systematic screening for active TB: from guideline to implementation Tuberculosis Knut Lonnroth (Switzerland) 115
16. Community as partner: creating successful collaborations in TB control Civil Society D'Arcy Richardson (USA),
Hara Mihalea (Thailand)
17. Community-based approaches to address lung health Adult and Child Lung Health Anne Detjen (USA),
Asma El Sony (Sudan)
18. Non-tuberculous mycobacterial infections: diagnosis and management TB/Bacteriology and Immunology Kauser Jabeen (Pakistan) 120/121

Friday, 31 October 2014 - 08:00 - 10:00

19. The Union/CDC Late breaker session Tuberculosis Richard Hafner (USA), CN Paramasivan (India),            Sarita Shah (USA) 112
20. Community-driven psychosocial support: don't forget medication counselling! TB/ Nurses and Allied Professionals Niranjan Konduri (USA),
Antonia Kwiecien (USA)
21. Practical considerations for successful contact tracing and linkage to care in low- and middle-income countries Tuberculosis E Jane Carter (USA),
Anna Mandalakas (USA)
22. Countries' experience in decentralising PMDT: community-based MDR-/XDR-TB care Tuberculosis Agnes Gebhard (Netherlands),
Alexander Golubkov (USA)
23. QMS implementation and accreditation of TB laboratories TB/Bacteriology and Immunology Stella Van Beers (Netherlands), Heidemarie Albert (South Africa) 114
24. Mathematical approaches to better understand and tackle tuberculosis Tuberculosis Cris Vilaplana (Spain),
Pere-Joan Cardona (Spain)
25. Tobacco control, trade and international treaties Tobacco Pranay Lal (India) 116
26. Know your epidemic: fundamental to solutions for child TB Adult and Child Lung Health Stephen M Graham (Australia) 118/119
27. What practical steps are needed to achieve a patient-centered continuum of care in TB control? Civil Society Virginia Williams (Switzerland),
Sara Massaut (Netherlands)

Friday, 31 October 2014 - 14:30- 16:30

28. Adolescent TB, TB-HIV and MDR-TB: addressing a vulnerable population with unique needs using innovative Adult and Child Lung Health Lisa Nelson (Switzerland) 112
29. Management of latent tuberculosis infection: from evidence to policy Tuberculosis Alberto Matteelli (Italy),
Andreas Sandgren (Sweden)
30. TB in Europe: MDR-/XDR-TB control and challenges of high risk groups Tuberculosis Dominik Zenner (UK),
Andrei Dadu (Moldova)
31. Implementing "FAST": a re-focused approach to institutional TB transmission control Tuberculosis Edward Nardell (USA) 113
32. Changing the status quo in TB drug and regimen R&D Tuberculosis Grania Brigden (France) 114
33. TB patients: learning from the experience of those personally affected Civil Society Victoria Garland (USA),
Jenniffer Dietrich (Switzerland)
34. Supervision or support? A debate panel on challenges around DOT and patient-centered care TB/ Nurses and Allied Professionals Tiemi Arakawa (Brazil) 116
35. Biosafety for TB laboratories: involving local professional associations in practical sustainable approaches TB/Bacteriology and Immunology Maureen Ellis (Canada) 118/119
36. Tobacco, poverty and possible solutions: health promotion funding models Tobacco Kayleigh Bleymann (UK),
Jonathan Romo (Mexico)

Saturday, 1 November 2014 - 09:15 - 11:15

37. HIV/TB Late-breaker session HIV/TB Section Officers  112
38. Progress and lessons learnt from national TB prevalence surveys Tuberculosis Ikushi Onozaki (Switzerland),   Marina Tadolini (Italy) 117
39. Engaging communities of special risk groups in conflict affected communities Tuberculosis Oriol Ramis (Spain),
Lucie Blok (Netherlands)
40. Tuberculosis infection control and occupational TB among health care workers: a time for action Tuberculosis Carrie Tudor (USA),
Rose Pray (USA)
41. Moving the next generation of TB diagnostics for drug resistance closer to patients: data sharing TB/Bacteriology and Immunology John Ridderhof (USA),
Siva Danaviah (South Africa)
42. Emerging perspectives in the treatment of paediatric MDR-TB Adult and Child Lung Health Anneke Hesseling (South Africa),
James Seddon (UK)
43. Magic bullet? Data-driven insights on the impact of community workers on case detection and treatment outcomes TB/ Nurses and Allied Professionals Ellen H Mitchell (Netherlands) 118/119
44. Zoonotic tuberculosis: a global socio-economic problem TB/ Zoonotic TB Adrian Muwonge (Uganda) 120/121
45. Partnerships: working for community-driven impact to ensure quality care for persons affected by TB Civil Society Thomas Mohr (Kazakhstan),
Jenniffer Dietrich (Switzerland)

Saturday, 1 November 2014 - 14:00 - 16:00

46. Innovative solutions in surveillance of drug-resistant TB: from phenotypic to molecular testing TB/Bacteriology and Immunology Ananta Nanoo (South Africa),
Alaine Umubyeyi Nyaruhirira (South Africa)
47. Engaging communities in the fight against TB and HIV Civil Society Mandy Slutsker (USA),
Alisha Smith-Arthur (USA)
48. Multi-faceted regional response to tuberculosis in the mining sector in Southern Africa Tuberculosis Okore Okorafor (South Africa),
M. Thulani Mbatha (South Africa)
49. Developing a roadmap for integration of TB-HIV activities in maternal and child health settings HIV Surbhi Modi (USA),
Anna Mandalakas (USA)
50. Enhancing TB control with structural interventions: from incentives and enablers to social protection Tuberculosis Delia Boccia (UK),
Alexander Golubkov (USA)
51. COPD: diagnostic and therapeutic challenges in developing countries Adult and Child Lung Health Jean-William Fitting (Switzerland) 115
52. Reaching the unreached through new civil society initiatives integrating community-based TB activities Civil Society Petra Stankard (USA),
Thomas Joseph (India)
53. Non-communicable diseases and tobacco control Tobacco Gan Quan (China) 118/119